Professional Documents
Culture Documents
This Decision was assailed by petitioners before the Court of Appeals and this Court,
but for naught.
The present Motion for Reconsideration advances four main arguments: that the
Court erroneously relied on a conjectural presumption that Tecson's relationship
might compromise the interest of the company or allow a competitor to gain access
to Glaxo's secrets and procedures; that Glaxo's policy regarding the marriage of its
employees to employees of rival companies is contrary to public policy, morals and
good customs; that Glaxo violated its own policy which authorized the transfer of
the subject employee to another department when it denied Tecson's application to
transfer to the milk division; and that Tecson was constructively dismissed when he
was transferred to the Butuan City-Surigao City-Agusan del Sur sales area.
One of the central anchors of the assailed Resolution was the holding that Glaxo's
policy on marriage did not violate the equal protection clause of the Constitution,2
as the constitutional guarantee does not encompass discriminatory behavior
engaged by private individuals.3 Petitioners do not challenge this holding of the
Court, and we see no reason to revisit this issue.
But before we engage in a renewed discussion on the validity of Glaxo's policy itself,
we should examine the claim that Tecson was constructively dismissed. After all,
assuming that the policy itself were declared invalid, a finding nonetheless that
Tecson was not constructively dismissed would still render this petition futile. The
Court has ruled Tecson was not actually dismissed, and the Motion for
Reconsideration adduces no substantial reasons why this holding should be
reversed.
The Resolution cited Abbott Laboratories (Phils.), Inc. v. NLRC4 wherein the Court
upheld the prerogative of a drug company to reassign a medical representative
under its employ to a new territory. In the same vein, the Court has consistently
affirmed as a valid prerogative of the employer the reasonable reassignment or
transfer of an employee. As held in Philippine Japan Active Carbon Corp. v. NLRC:5
It is the employer's prerogative, based on its assessment and perception of its
employees' qualifications, aptitudes, and competence, to move them around in the
various areas of its business operations in order to ascertain where they will
function with maximum benefit to the company. An employee's right to security of
tenure does not give him such a vested right in his position as would deprive the
company of its prerogative to change his assignment or transfer him where he will
be most useful. When his transfer is not unreasonable, nor inconvenient, nor
prejudicial to him, and it does not involve a demotion in rank or a diminution of his
salaries, benefits, and other privileges, the employee may not complain that it
amounts to a constructive dismissal.6
In Philippine Telegraph and Telephone Corp. v. Laplana,7 the Court again upheld the
prerogative of management to reassign an employee to a different locality, despite
than most other competitive industries. To that end, Glaxo is entitled to guard its
trade secrets, manufacturing formulas, marketing strategies and other confidential
programs and information from competitors, concomitant to its right to protect its
own economic interests.
This in mind, it is but reasonable for Glaxo to be cautious about the social
interaction of its employees with those of companies which it directly competes
with. If the employee goes as far as sharing hearth and home with the employee of
the rival company, there is greater cause of concern on the part of Glaxo. The fear
may not so much arise from the possibility of willful betrayal by its employees of
trade secrets, but from the myriad opportunities in the course of shared lives that
one may inadvertently divulge to the spouse confidential information that the rival
drug company may benefit from. After all, the employer has no control over pillow
talk. Neither could it be expected that the employee maintain a higher fidelity to the
employer than to the spouse.
It may be so, as petitioners argue, much of the fear is hypothetical in nature. Yet
Glaxo, as with any other industry, is allowed to take reasonable steps in order to
prevent potential damage from becoming actual, especially if the economic
consequences are substantial. Glaxo is hardly a small-scale industry, and the
pharmaceutical business seldom characterized by old-fashioned rectitude.
Still, these concerns aside, the steps that Glaxo may employ to avoid the undue
divulgence of its trade secrets should be within reason. If termination is to be
considered as an option, it should be only as a final resort, if there is no other way
to avoid the conflict of interest.
In this case, Glaxo's assailed policy does not call for automatic termination,
providing as it does a process that allows for all the opportunities for a mutually
agreeable solution. Per the Employee Handbook, "every effort shall be made,
together by management and the employee, to arrive at a solution within six (6)
months, either by transfer to another department in a non-counter checking
position, or by career preparation toward outside employment after Glaxo
Wellcome. Employees must be prepared for possible resignation within six (6)
months, if no other solution is feasible."21
This procedure is extremely reasonable under the circumstances, and we have no
problems in upholding its validity. As noted in the Resolution: "[i]n any event, from
the wordings of the contractual provision and the policy in its employee handbook,
it is clear that Glaxo does not impose an absolute prohibition against relationships
between its employees and those of competitor companies. Its employees are free
to cultivate relationships with and marry persons of their own choosing."22 It
recognizes the concern arising from the possible conflict of interest, yet dissuades
the enforcement of a hasty, unilateral solution. It appears from the record of this
case that such a procedure was adopted in good faith by both parties. Tecson may
find fault with the fact that Glaxo refused his request for transfer to the milk
division, a step which, if resorted to, may have resolved the perceived conflict of
interest. Yet the procedure involved allows the transfer only if mutually agreed
upon, and besides, employees cannot generally compel the employer to transfer
them from one division to another, this being a management prerogative.
And finally, if no mutual resolution is arrived at, termination and voluntary
resignation remain as viable options. Neither obtained in this case, and we have
already ruled that the transfer was valid and did not constitute constructive
dismissal. If Glaxo, or any employer with a similarly drawn-out procedure, were to
ultimately resort to termination, the burden would still fall upon it to establish that
such termination is in accordance with the just causes as provided in Article 282 of
the Labor Code. Without such linkage, the termination would be invalid.
The fact that there was no actual termination in this case obviates the need for us
to further apply Article 282 or the jurisprudential rules on illegal termination to this
case.
Still, should Glaxo retain the said policy, and another employee trek the same trail
as Tecson did, it cannot be foreordained that the Court would similarly rule for Glaxo
and against the said employee. As repeatedly emphasized, it all depends on the
particular circumstances of each case. And ultimately, if dismissal, constructive or
otherwise, is resorted to, the standards for termination set by the Labor Code must
still be complied with.
WHEREFORE, petitioner's Motion for Reconsideration is DENIED WITH FINALITY.
Very truly yours,
(Sgd.) LUDICHI YASAY-NUNAG
Clerk of Court